Furthermore, in T2DM patients without end-stage renal failure, GSTP1 rs1695 and predicted GSTP1 activity were nominally associated with the development and severity of albuminuria [40]. This evidence concerns the gene GSTP1 and stage 5 chronic kidney disease.